Mylan, Abbott Bury Hatchet Over Depakote ER
Mylan Pharmaceuticals Inc. and Abbott Laboratories have reached a truce in their long-standing battle over Depakote, as Mylan won permission to sell a knockoff version of Abbott's best-selling extended-release epilepsy drug....To view the full article, register now.
Already a subscriber? Click here to view full article